Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

Group 1 - Abeona Therapeutics Inc. will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 6, 2024, at 11:30 a.m. Eastern Time [1] - The company will also engage in one-on-one investor meetings during the conference [1] - A live webcast of the fireside chat will be available on the company's website and archived for 30 days [1] Group 2 - Abeona Therapeutics is a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for serious diseases [2] - The company's investigational product, Prademagene zamikeracel (pz-cel), is in development for recessive dystrophic epidermolysis bullosa [2] - Abeona has a fully integrated cGMP manufacturing facility that supports the production of pz-cel for its Phase 3 VIITAL™ trial and potential commercial production upon FDA approval [2] - The company is also developing AAV-based gene therapies for ophthalmic diseases with high unmet medical needs, utilizing next-generation AAV capsids to improve tropism profiles [2]